The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

DPH DECHRA PHARMACEUTICALS PLC ORD 1P




Fundamentals data is provided by FTSE Russell Data Solutions. To provide comparable issuer data, information has been standardised by FTSE Russell Data Solutions using globally adopted XBRL taxonomies. The data presented may therefore differ from an issuer's annual report and 'as reported' data should be obtained directly from the source issuer.

Data is provided "AS IS", with all faults, and on an "AS AVAILABLE" basis for information purposes only. London Stock Exchange is not liable for any errors, omissions or other defects in the data, or for any decisions taken in reliance of the data. Please see our full disclaimer here: https://www.londonstockexchange.com/global/legal/disclaimer.htm
Income Statement 30-Jun-14
( £ m )
30-Jun-15
( £ m )
30-Jun-16
( £ m )
30-Jun-17
( £ m )
30-Jun-18
( £ m )
Continuing Operations
Revenue  193.57 203.48 247.56 359.28 407.10
Operating Profit/(Loss)  25.00 25.98 19.49 33.21 34.10
Net Interest  -2.47 -1.47 -2.37 -4.85 -6.70
Profit Before Tax  21.44 25.81 14.55 28.72 29.20
Profit After Tax  19.42 19.46 12.51 26.27 36.40
Discontinued Operations
Profit After Tax  39.63 n/a n/a n/a n/a
PROFIT FOR THE PERIOD  59.05 19.46 12.51 26.11 36.10
Attributable to:
Minority Interests  n/a n/a 0.16 0.00 n/a
Equity Holders of Parent Company  59.05 19.46 12.67 26.10 36.10
 
Continuing EPS
Earnings per Share - Basic  22.22p 22.14p 14.00p 28.09p 37.24p
Earnings per Share - Diluted  22.14p 21.99p 13.90p 27.93p 37.04p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  67.57p 22.14p 14.00p 28.09p 37.24p
Earnings per Share - Diluted  67.33p 21.99p 13.90p 27.93p 37.04p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  n/a 16.94p 18.46p 21.44p 25.50p

Balance Sheet 30-Jun-14
( £ m )
30-Jun-15
( £ m )
30-Jun-16
( £ m )
30-Jun-17
( £ m )
30-Jun-18
( £ m )
Assets
Non-Current Assets
Property, Plant & Equipment  18.26 16.82 37.72 45.20 45.30
Intangible Assets  196.18 166.68 360.38 396.26 709.80
Investment Properties  n/a n/a n/a n/a n/a
Investments  n/a n/a n/a 10.85 10.50
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  214.44 183.51 398.30 453.09 769.40
Current Assets
Inventories  29.67 31.74 54.38 56.51 86.60
Trade & Other Receivables  29.89 30.93 68.94 67.27 81.60
Cash at Bank & in Hand  26.77 45.95 39.14 61.20 79.70
Current Asset Investments  n/a n/a n/a n/a n/a
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  86.33 108.62 162.46 184.98 247.90
 
Total Assets  300.77 292.13 560.75 638.07 1017.30
 
Liabilities
Current Liabilities
Borrowings  0.10 0.01 1.67 0.97 1.20
Other Current Liabilities  22.74 33.73 40.26 44.00 57.40
  35.72 44.11 66.26 66.41 91.60
 
Net Current Assets  50.62 64.52 96.20 118.56 156.30
 
Non-Current Liabilities
Borrowings  31.66 32.52 154.09 180.19 289.90
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  6.02 3.41 6.50 36.55 30.80
  60.25 53.53 217.88 269.02 420.70
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  95.97 97.64 286.12 337.00 512.30
 
Net Assets  204.81 194.49 274.63 301.07 505.00
 
Capital & Reserves
Share Capital  n/a 0.88 0.93 0.93 1.00
Share Premium Account  124.43 124.80 172.45 173.38 359.30
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  87.49 94.98 94.00 107.42 125.50
Shareholders Funds  204.81 194.49 274.63 301.07 505.00
 
Minority Interests/Other Equity  n/a n/a 1.98 1.56 n/a
Total Equity *   204.81 194.49 276.61 302.64 505.00

Ratios - based on IFRS 30-Jun-14 30-Jun-15 30-Jun-16 30-Jun-17 30-Jun-18
Continuing Operations
PE Ratio *   32.56 44.40 83.71 60.52 74.70
PEG *   0.14 -0.66 -2.27 0.60 2.29
Earnings per Share Growth  228.17% -67.23% -36.94% 101.19% 32.57%
Dividend Cover *   n/a 1.31 0.76 1.31 1.46
Revenue Per Share  221.51p 231.52p 276.22p 386.47p 419.94p
Pre-Tax Profit per Share  24.54p 29.36p 16.23p 30.90p 30.12p
Operating Margin  12.91% 12.77% 7.87% 9.24% 8.38%
Return on Capital Employed  9.53% 11.21% 5.91% 7.28% 5.34%
 
Continuing & Discontinued Operations
Dividend Yield *   n/a 1.72% 1.58% 1.26% 0.92%
Dividend per Share Growth  n/a n/a 8.68% 16.46% -37.97%
Net Asset Value per Share (exc. Intangibles)  9.83p 31.61p -92.46p -102.16p -200.18p
Net Gearing *   2.44% -6.90% 42.47% 39.84% 41.86%

Data provided by FTSE Russell



Company Information
Company website http://www.dechra.com
Company address 24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, CW9 7UA, United Kingdom
FTSE ICB sector Pharmaceuticals, Biotechnology and Marijuana Producers
FTSE ICB subsector Pharmaceuticals
Company market cap, £m* 3,013.21
Admission date 21 Sep 2000
*The company market capitalization reflects the London listed element of Ordinary and Preference shares only and is approximate. Data provided by FTSE Russell.


Security Information
FTSE index FTSE 250,FTSE MID 250 (ex IT),FTSE 350,FTSE 350 Low Yield,FTSE 350 (ex IT),FTSE All-Share,FTSE All-Share (ex IT)
Market Main Market
Market identifier code (MIC) XLON
Trading service SETS
Trading segment STMM
Listing category Premium Equity Commercial Companies
Country of share register GB
ISIN GB0009633180
SEDOL 0963318
Exchange market size 750
Security market cap, £m 3,013.21
*The market capitalisation of the security reflects data from previous trading day.


DECHRA PHARM share fundamentals (DPH)